Cortland Advisers Position in Nextera Energy (NEE) Decreased by $2.25 Million as Shares Rose; Genomic Health Com (GHDX) Shareholder Bogle Investment Management LP Has Decreased Holding as Stock Rose

February 24, 2018 - By Louis Casey

Bogle Investment Management Lp decreased its stake in Genomic Health Inc Com (GHDX) by 26.65% based on its latest 2017Q3 regulatory filing with the SEC. Bogle Investment Management Lp sold 16,136 shares as the company’s stock rose 1.41% with the market. The institutional investor held 44,405 shares of the health care company at the end of 2017Q3, valued at $1.42 million, down from 60,541 at the end of the previous reported quarter. Bogle Investment Management Lp who had been investing in Genomic Health Inc Com for a number of months, seems to be less bullish one the $1.14 billion market cap company. The stock increased 4.39% or $1.38 during the last trading session, reaching $32.78. About 251,600 shares traded or 28.38% up from the average. Genomic Health, Inc. (NASDAQ:GHDX) has risen 23.46% since February 24, 2017 and is uptrending. It has outperformed by 6.76% the S&P500.

Cortland Advisers Llc decreased its stake in Nextera Energy Inc (NEE) by 2.75% based on its latest 2017Q3 regulatory filing with the SEC. Cortland Advisers Llc sold 15,400 shares as the company’s stock rose 8.22% with the market. The institutional investor held 544,100 shares of the public utilities company at the end of 2017Q3, valued at $79.74 million, down from 559,500 at the end of the previous reported quarter. Cortland Advisers Llc who had been investing in Nextera Energy Inc for a number of months, seems to be less bullish one the $73.57 billion market cap company. The stock increased 2.59% or $3.95 during the last trading session, reaching $156.26. About 1.82M shares traded. NextEra Energy, Inc. (NYSE:NEE) has risen 15.94% since February 24, 2017 and is uptrending. It has underperformed by 0.76% the S&P500.

Among 11 analysts covering Genomic Health (NASDAQ:GHDX), 2 have Buy rating, 3 Sell and 6 Hold. Therefore 18% are positive. Genomic Health had 31 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Genomic Health, Inc. (NASDAQ:GHDX) has “Hold” rating given on Tuesday, September 12 by Jefferies. As per Wednesday, September 2, the company rating was initiated by Barclays Capital. The stock has “Neutral” rating by Piper Jaffray on Monday, January 11. William Blair downgraded Genomic Health, Inc. (NASDAQ:GHDX) on Wednesday, December 20 to “Hold” rating. Canaccord Genuity maintained Genomic Health, Inc. (NASDAQ:GHDX) rating on Tuesday, January 16. Canaccord Genuity has “Buy” rating and $42.0 target. The firm has “Sell” rating by Zacks given on Monday, August 24. Cowen & Co downgraded the shares of GHDX in report on Wednesday, January 4 to “Market Perform” rating. The rating was maintained by Jefferies on Friday, October 20 with “Hold”. JP Morgan downgraded the shares of GHDX in report on Wednesday, December 13 to “Underweight” rating. The rating was maintained by Jefferies on Wednesday, August 17 with “Hold”.

Since September 12, 2017, it had 0 insider purchases, and 14 insider sales for $3.55 million activity. Popovits Kimberly J had sold 10,000 shares worth $329,336 on Wednesday, February 14. Leber Laura had sold 21,000 shares worth $699,000 on Thursday, December 14. Another trade for 4,942 shares valued at $162,290 was made by Febbo Phillip G. on Tuesday, February 20. Vaughn James J sold 3,004 shares worth $102,406.

Bogle Investment Management Lp, which manages about $2.60B and $1.47 billion US Long portfolio, upped its stake in Bottomline Technologies Inc (NASDAQ:EPAY) by 58,740 shares to 114,384 shares, valued at $3.64M in 2017Q3, according to the filing. It also increased its holding in Bonanza Creek Energy I Com by 11,291 shares in the quarter, for a total of 77,227 shares, and has risen its stake in National Cinemedia Inc Com (NASDAQ:NCMI).

Investors sentiment increased to 2.32 in Q3 2017. Its up 0.66, from 1.66 in 2017Q2. It increased, as 6 investors sold GHDX shares while 25 reduced holdings. 21 funds opened positions while 51 raised stakes. 30.86 million shares or 1.02% more from 30.55 million shares in 2017Q2 were reported. Federated Investors Pa stated it has 0% of its portfolio in Genomic Health, Inc. (NASDAQ:GHDX). 208 are owned by First Quadrant Lp Ca. 200 are owned by Plante Moran Advisors Ltd Liability Com. Camber Mgmt Lc reported 2.46M shares. Metropolitan Life Insur New York accumulated 13,242 shares. New York-based Bnp Paribas Arbitrage Sa has invested 0% in Genomic Health, Inc. (NASDAQ:GHDX). Deutsche Financial Bank Ag reported 31,640 shares. Smithfield Tru reported 0% stake. Illinois-based State Farm Mutual Automobile has invested 0.01% in Genomic Health, Inc. (NASDAQ:GHDX). Sei Invests, Pennsylvania-based fund reported 113 shares. Jefferies Grp Inc Limited Co has invested 0% in Genomic Health, Inc. (NASDAQ:GHDX). Cornerstone Cap Mgmt Hldg Ltd owns 16,337 shares. Voya Mgmt Limited Liability Corp stated it has 0% in Genomic Health, Inc. (NASDAQ:GHDX). Piermont Mngmt holds 6,320 shares. Pnc Services Grp has invested 0% in Genomic Health, Inc. (NASDAQ:GHDX).

Since September 18, 2017, it had 0 buys, and 5 sales for $7.05 million activity. $1.40M worth of NextEra Energy, Inc. (NYSE:NEE) shares were sold by Pimentel Armando Jr. Shares for $435,000 were sold by KETCHUM JOHN W. Shares for $439,881 were sold by Sieving Charles E.

Investors sentiment decreased to 0.95 in Q3 2017. Its down 0.02, from 0.97 in 2017Q2. It dropped, as 38 investors sold NEE shares while 396 reduced holdings. 89 funds opened positions while 323 raised stakes. 344.40 million shares or 7.22% less from 371.19 million shares in 2017Q2 were reported. Mcrae Cap stated it has 3,000 shares. Fmr Ltd holds 0.14% or 8.03M shares. Benjamin F Edwards And Company has invested 0.56% in NextEra Energy, Inc. (NYSE:NEE). The Maryland-based Pinnacle Advisory Group has invested 0.04% in NextEra Energy, Inc. (NYSE:NEE). Moreover, Thompson Siegel And Walmsley Limited Com has 0% invested in NextEra Energy, Inc. (NYSE:NEE) for 1,550 shares. Winfield Associates owns 540 shares. Fukoku Mutual Life Ins holds 0.13% or 6,000 shares. Amer Financial Bank holds 0.13% in NextEra Energy, Inc. (NYSE:NEE) or 3,041 shares. Welch & Forbes Limited Co reported 16,254 shares. 1,374 are held by Wms Prns Ltd Liability Company. Fruth Management accumulated 1,430 shares or 0.1% of the stock. Ameritas Prtn Inc has 30,488 shares. Virtus Advisers invested in 0.14% or 9,182 shares. Schafer Cullen Cap Management holds 1.6% or 904,388 shares in its portfolio. Davis R M invested in 0.01% or 2,333 shares.

Among 15 analysts covering Nextera Energy Inc. (NYSE:NEE), 13 have Buy rating, 0 Sell and 2 Hold. Therefore 87% are positive. Nextera Energy Inc. had 39 analyst reports since August 5, 2015 according to SRatingsIntel. Howard Weil initiated the stock with “Sector Outperform” rating in Tuesday, November 17 report. The stock of NextEra Energy, Inc. (NYSE:NEE) has “Overweight” rating given on Monday, November 13 by Morgan Stanley. The company was maintained on Friday, March 18 by Barclays Capital. Deutsche Bank maintained the shares of NEE in report on Monday, October 5 with “Buy” rating. The company was maintained on Friday, August 7 by Argus Research. The firm has “Overweight” rating given on Thursday, August 10 by Morgan Stanley. The firm has “Buy” rating given on Monday, July 24 by Goldman Sachs. The firm earned “Buy” rating on Tuesday, August 11 by M Partners. The firm has “Buy” rating given on Friday, June 2 by BMO Capital Markets. The stock of NextEra Energy, Inc. (NYSE:NEE) earned “Buy” rating by RBC Capital Markets on Sunday, November 5.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: